This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

9 Jul 2014

Registration for CPHI Worldwide Now Open

Registration for CPHI Worldwide is now open. Join UBM in Paris to enjoy the newest industry-related content and the most effective business networking events.


CPHI Worldwide attendees enjoyed UBM's most successful show yet in Frankfurt 2013, with 34,000 attendees and 2200 exhibitors from all around the world.


In 2014 CPHI is working hard to bring the best content, even more networking opportunities and exciting new programmes than ever before to celebrate #CPHI Worldwide 25th Anniversary!


Register now for free at


New exclusive programmes for 2014 edition:

• 25th Anniversary Networking Party: Wednesday, 8 October: a lavish cocktail party in downtown Paris! Network and entertain colleagues and clients. Tickets are available in the online show registration form, but hurry because tickets are limited and there are only 400 available.

• Innovation Gallery: See what's new in the industry. Exhibitors can now display their latest innovations and product launches in an eye-catching area on the show floor.

• Womens Networking Breakfast: Hear inspirational female speakers about women empowerment in the pharmaceutical industry and meet your female peers.

• Pre-Connect Congress: It is where the pharmaceutical industry meets on 6 October 2014 prior to CPHI Worldwide starting. There you can apply your mind into commercial and technical modules featuring the latest industry developments and hot topics that will shape the industry.

• Participants' view: “Pre-Connect provides a golden opportunity for thought leaders in pharma and bio to exchange their views and experiences; so to enhance their understanding and capability to influence the rapidly changing environment in which the industry operates,” explained Prof. Trevor M Jones, CBE Director of Allergen Inc (USA) and other international pharmaceutical companies, visiting professor of King’s College London. 

Related News